Vegalab Announces 2017 Financial Results

Acquisition of California Fruit and Vegetable Packing Operation Adds Synergistic Subsidiary

PALM BEACH, Fla., June 04, 2018 (GLOBE NEWSWIRE) -- Vegalab, Inc. ("the Company"), (OTCQB:VEGL) today announced its 2017 Financial Results. 

Vegalab Inc. holds the exclusive North and South America distribution rights to a suite of Earth friendly products that includes biological pesticides, natural fertilizers, and specialty biological products marketed under the “Vegalab” brand (“The Agronomy Business”).  Sales in 2017 slowed during the first three quarters due to a combination of adverse weather in California, and the Company’s customers using products left over from 2016 purchases. In the fourth quarter, however, the Company began selling its products through two of the twenty-five largest agricultural retailers in the United States, one of which agreed to a $13 million minimum purchase requirement for 2018 in its distribution agreement.

Management strategically grew the Company in October of 2017, with the acquisition of substantially all of the assets related to a produce packing business located in Tulare County, California (the "Packing Business").  The acquisition added tangible assets to the Company’s balance sheet of 11 acres of real property and 30,000 sq. ft. of buildings located in the heart of the California citrus growing region. The purchase included all equipment, inventory, customers, suppliers, contract rights, and intangible property of the prior owner/operators. In addition, this thirteen-year-old business, with annual revenues of $8.6 Million in 2016, produced immediate synergies and new opportunities. Recognizing the potential to dramatically increase capacity, the company invested $350,000 in equipment to increase pack line efficiency and cold storage space, changes that could increase production by 200%. Should demand warrant, by simply adding another shift the Company could potentially triple the revenue of the Packing Business and dramatically increase its profits.

The acquisition of the Packing Business is a part of the Company’s long-term plan to grow its business both organically and through strategic, geographically complimentary, acquisitions. Not only did the acquisition add immediate cash flow and incremental revenues to the Company, with several customers of the Packing Business already using Vegalab's all natural products to maximize yields and increase the number of premium quality fruits produced in their citrus groves, the acquisition provides synergistic growth opportunities for both the Company’s Packing Business and the Company’s Agronomy Business.

David Selakovic, CEO of Vegalab, Inc., stated; “In the next few weeks, we will announce our First Quarter Earnings for Fiscal Year 2018.  We look forward to sharing the successful business trajectory of Vegalab Inc., as we expand the Company’s offerings and operations while pursuing new markets and business opportunities in North and South America.” 

Results of Operations

During the year ended December 31, 2017, the Company recognized total revenues of $2,491,391 compared to $2,115,421 for the year ended December 31, 2016, including sales of $361,083 from the sale of Vegalab products compared to $2,115,421 for the year ended December 31, 2016. Product sales in 2017 slowed until the fourth quarter, due to a combination of adverse weather in California and our customers using products carried over from purchases in mid to late 2016. On October 18, 2017, the Company purchased substantially all the assets of a produce packaging business conducted under the name M&G Packing, Inc. From October 18, 2017 through December 31, 2017 the Company generated revenues of $2,130,308 from processing revenue.

Cost of goods sold were $2,057,619 for the year ended December 31, 2017, Compared to $1,617,366 for the year ended December 31, 2016. Cost of goods sold for our Vegalab products decreased due to reduced sales of Vegalab products. Cost of goods of $1,774,279 on our produce packaging business was under M&G Packing, Inc. from October 18, 2017 through December 31, 2017. During the year ended December 31, 2017 expenses increased significantly as the Company hired additional staff, consultants and professionals due to its purchase of M&G Packing, Inc. During the year ended December 31, 2017 the Company recorded an expense of $180,181 as an impairment of assets acquired in its purchase of M&G Packaging, Inc.

Total operating expenses for the year ended December 31, 2017, were $2,116,404 compared to $593,334 for the year ended December 31, 2016. For the year ended December 31, 2017, loss from operations was $1,682,632 compared to 95,279 for the year ended December 31, 2016.

After the provision for income taxes, net loss for the year ended December 31, 2017, was $1,673,779 or $0.08 per share, and the net loss for the year ended December 31, 2016 was $116,361 or $0.01 per share.

About Vegalab, Inc.

Vegalab, Inc. is the exclusive distributor in North and South America of a line of all-natural, biologically derived pesticides, fertilizers, and specialty agricultural products. Vegalab’s pesticides are highly effective against targeted organisms, non-toxic to beneficial organisms, and safe for the environment. Vegalab products support a healthy soil biome and are cost competitive with synthetic chemicals that do just the opposite. The Company operates in two segments of the food industry:  The Agronomy Business and the Packing Business. The Agronomy Business involves the manufacture and distribution of all-natural crop protection, crop health, and soil enhancement products, and The Packing Business is the operation of a citrus packing facility.

Safe Harbor for Forward-looking Statements

This news release may contain forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the Company's progress, business opportunities, and growth prospects, they are based on management's current beliefs and assumptions as to future events. However, since the Company's operations and business prospects are always subject to risk and uncertainties, the forward-looking events and circumstances discussed in this news release might not occur, and actual results could differ materially from those described, anticipated, or implied. For a more complete discussion of such risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.

Contact:

Sean Leous
Media Relations
Vegalab Inc
636 US Highway 1, suite 110
North Palm Beach, FL 33408, US
T + 800 208 1680 ext 714
http://vegalab.us

Vegalab, Inc. (formerly HPC Acquisitions, Inc.)
Consolidated Balance Sheets 
  As of   As of
  December 31,   December 31,
    2017       2016  
ASSETS      
Current Assets      
  Cash and cash equivalents $   342,534     $   151  
  Accounts receivable, net     1,674,583         671,279  
  Inventory     1,595,148         1,889,423  
  Prepaid expenses     339,389         20,540  
Total Current Assets     3,951,654         2,581,393  
Fixed assets, net     821,322         -   
Deposits     14,500      14,500- 
Total assets $   4,787,476     $   2,595,893  
       
LIABILITIES AND STOCKHOLDERS’ EQUITY      
       
Current Liabilities      
  Accounts payable – trade $   409,239     $   67,563  
  Accounts payable – related party     712,947         1,727,857  
  Accrued amounts owed to growers     860,694         -   
  Accrued income taxes     -          17,036  
  Accrued interest payable - related party     1,894         2,474  
  Note Payable - Current Portion     2,904         -   
  Capital lease obligation - Current Portion     3,409         -   
  Notes payable related party     -          175,000  
Total Current Liabilities     1,991,087         1,989,930  
       
  Capital lease obligations     18,235         -  
  Notes payable     428,958         -  
Total Liabilities     2,438,280         1,989,930  
       
Commitments and Contingencies      
       
Stockholders’ Equity      
  Preferred stock – $0.001 par value, 10,000,000 shares authorized, none issued and outstanding     -          -   
  Common stock – $0.001 par value, 50,000,000 shares authorized, 23,162,897 and 20,140,000
  shares issued and outstanding, respectively
    23,163         20,140  
Additional paid-in capital     4,791,488         1,377,499  
Accumulated deficit     (2,465,455 )       (791,676 )
       
Total Stockholders’  Equity     2,349,196         605,963  
       
Total Liabilities and Stockholders’ Equity $   4,787,476     $   2,595,893  
 
The accompanying notes are an integral part of these consolidated financial statements.


Vegalab, Inc. (formerly HPC Acquisitions, Inc.)      
Consolidated Statements of Operations      
For the Years Ended December 31, 2017 and 2016      
    2017       2016  
       
Revenues:     -       
Processing Revenue $   2,130,308         -   
Products sales     361,083         2,115,421  
  Total Revenue     2,491,391         2,115,421  
       
Cost of Goods Sold:      
Cost of processing     1,774,279         -   
Cost of Goods Sold     283,340         1,617,366  
  Total Cost of Goods Sold     2,057,619         1,617,366  
       
Gross Profit     433,772         498,055  
       
Operating expenses      
  General and administrative expenses     1,936,223         593,334  
  Loss on impairments     180,181        -  
       
  Total operating expenses     2,116,404         593,334  
       
Loss from operations     (1,682,632 )       (95,279 )
       
Other income (expense)      
  Interest Expense     (8,183 )       (4,046 )
       
  Loss before provision for income taxes     (1,690,815 )       (99,325 )
       
Provision for income taxes     (17,036 )       17,036  
       
Net Loss $   (1,673,779 )   $   (116,361 )
       
Loss per weighted-average shares of common stock outstanding - basic and fully diluted $   (0.08 )   $   (0.01 )
       
Weighted-average number of common shares outstanding - basic and fully diluted     21,004,615         17,669,571  
 
The accompanying notes are an integral part of these consolidated financial statements.


 

Vegalab, Inc. (formerly HPC Acquisitions, Inc.)
     
Consolidated Statements of Changes in Stockholders’ Equity      
For the Years ended December 31, 2017 and 2016      
                   
           Additional        
  Common Stock    paid-in    Accumulated    
  Shares    Amount    capital    deficit    Total
                   
Balance at December 31, 2015 6,989,000   $   6,989   $   503,380   $   (675,315 )   $   (164,946 )
                   
Sale of common stock for cash 13,011,000       13,011       690,089       -          703,100  
                   
Common stock issued for services 140,000       140       184,030       -          184,170  
                   
Net Loss for the year   -        -        -        (116,361 )       (116,361 )
                   
Balance at December 31, 2016 20,140,000   $   20,140   $   1,377,499   $   (791,676 )   $   605,963  
                   
Sale of common stock for cash 2,822,899       2,822       2,537,779       -          2,540,601  
                   
Common stock issued for services 200,000       200       325,800       -          326,000  
                   
Compensation expense associated with option awards   -            550,411       -          550,411  
          -             
Net Income for the year   -        -        -        (1,673,779 )       (1,673,779 )
                    . 
Balance at December 31, 2017 23,162,899   $   23,162   $   4,791,489   $   (2,465,455 )   $   2,349,196  
 
The accompanying notes are an integral part of these consolidated financial statements.
 


Vegalab, Inc. (formerly HPC Acquisitions, Inc.)      
Consolidated Statements of Cash Flows      
For the Years Ended December 31, 2017 and 2016      
    2017       2016  
Cash flows from operating activities      
  Net income (loss) for the period $   (1,673,779 )   $   (116,361 )
  Adjustments to reconcile net loss to net cash provided by operating activities      
  Depreciation expense     20,362         -   
  Impairment of fixed assets     180,181         -   
  Stock option expense     550,411         -   
  Common stock issued for services     27,162         184,170  
  (Increase) Decrease in      
  Accounts receivable     (1,003,305 )       (671,279 )
  Inventory     294,275         (1,889,423 )
  Prepaid expenses     (20,016 )       (33,790 )
  Increase (Decrease) in      
  Accounts payable     1,202,373         64,811  
  Accounts payable – related party     (1,012,436 )       1,727,857  
  Accrued income taxes    (17,036 )       17,036  
  Accrued interest    -          (7,643 )
  Accrued interest payable to controlling stockholder    (580  )       (21,953 )
       
  Net cash used in operating activities     (1,452,388 )       (746,575 )
       
Cash flows from investing activities      
  Purchase of fixed assets     (566,460 )       -   
  Net Cash flows from investing activities     (566,460 )       -   
       
Cash flows from financing activities      
Cash paid on notes payable to investors     -          (122,300 )
Cash received / (repaid) from issuance of note payable – related party     (177,474 )       175,000  
  Cash received (paid) on notes payable to controlling stockholder, net     -          (87,352 )
  Cash paid on vehicle loan     (1,899 )      -   
  Proceeds from sale of common stock     2,540,604         703,100  
       
  Net cash provided by financing activities     2,361,231         668,448  
    .     
Increase (decrease) in Cash     342,383         (78,127 )
       
Cash at beginning of period     151         78,278  
       
Cash at end of period $   342,534     $   151  
       
  Supplemental disclosure of interest and income taxes paid      
  Interest paid for the period $   10,657     $   34,244  
  Income taxes paid for the period     -          -   
       
NON-CASH TRANSACTIONS:      
  Fixed assets acquired through issuance of debt $   8,761         -   
  Fixed assets acquired through issuance of debt -M&G acquisition $   425,000         -   
  Capital lease obligation $   21,644         -   
 
The accompanying notes are an integral part of these consolidated financial statements.

Source: Vegalab Inc.